wu yun - Net Worth and Insider Trading
wu yun Net Worth
The estimated net worth of wu yun is at least $2 Million dollars as of 2025-04-13. wu yun is the Director of Jiangsu Kanion Pharmaceutical Co Ltd and owns about 150,000 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) stock worth over $2 Million. Details can be seen in wu yun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that wu yun has not made any transactions after 2022-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of wu yun
wu yun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, wu yun owns 1 companies in total, including Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) .
Click here to see the complete history of wu yun’s form 4 insider trades.
Insider Ownership Summary of wu yun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600557 | Jiangsu Kanion Pharmaceutical Co Ltd | 2022-09-26 | Director |
wu yun Latest Holdings Summary
wu yun currently owns a total of 1 stock. wu yun owns 150,000 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) as of September 26, 2022, with a value of $2 Million.
Latest Holdings of wu yun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600557 | Jiangsu Kanion Pharmaceutical Co Ltd | 2022-09-26 | 150,000 | 12.82 | 1,923,000 |
Holding Weightings of wu yun
wu yun Form 4 Trading Tracker
According to the SEC Form 4 filings, wu yun has made a total of 1 transactions in Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Jiangsu Kanion Pharmaceutical Co Ltd is the sale of 150,000 shares on September 26, 2022, which brought wu yun around $1 Million.
Insider Trading History of wu yun
- 1
wu yun Trading Performance
GuruFocus tracks the stock performance after each of wu yun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by wu yun is 44.67%. GuruFocus also compares wu yun's trading performance to market benchmark return within the same time period. The performance of stocks bought by wu yun within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how wu yun's insider trading performs compared to the benchmark.
Performance of wu yun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 54.26 |  | | | | |
| Relative Return to S&P 500(%) | 49.46 | | | | | |
wu yun Ownership Network
Ownership Network List of wu yun
Ownership Network Relation of wu yun
wu yun Owned Company Details
What does Jiangsu Kanion Pharmaceutical Co Ltd do?
Who are the key executives at Jiangsu Kanion Pharmaceutical Co Ltd?
wu yun is the Director of Jiangsu Kanion Pharmaceutical Co Ltd. Other key executives at Jiangsu Kanion Pharmaceutical Co Ltd include and senior management Wan Yan Huan .
Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jiangsu Kanion Pharmaceutical Co Ltd Insider Transactions
wu yun Mailing Address
Above is the net worth, insider trading, and ownership report for wu yun. Currently GuruFocus does not have mailing address information for wu yun.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
